SMITHS
FALLS, ON, May 13, 2022 /PRNewswire/ - Canopy Growth
Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ:
CGC) will release its financial results for the fourth quarter and
fiscal year 2022 ended March 31,
2022, before financial markets open on May 27, 2022.
Following the release of its fourth quarter and fiscal year 2022
financial results, Canopy Growth will host an audio webcast with
David Klein, CEO and Judy Hong, CFO at 10:00
AM Eastern Time on May 27, 2022.
Beginning this quarter, the Company will be using a question and
answer platform developed by Say Technologies to enhance
engagement with its shareholders, allowing verified retail and
institutional shareholders to submit and upvote questions.
Management will address a limited number of questions relating to
Canopy Growth's business and financial results during the Q&A
portion of the conference call. The platform will open on
May 20, 2022, at 10:00 a.m. ET and close on May 26, 2022, at 10:00
a.m. ET.
Shareholders can submit questions, after the platform opens, by
visiting
https://app.saytechnologies.com/canopy-growth-corporation-2022-q4.
Webcast Information
A live audio webcast will be available at:
https://produceredition.webcasts.com/starthere.jsp?ei=1540225&tp_key=a04693a9b2
Replay Information
A replay will be accessible by webcast until 11:59 PM ET on August 25,
2022, at:
https://produceredition.webcasts.com/starthere.jsp?ei=1540225&tp_key=a04693a9b2
About Canopy Growth Corporation
Canopy Growth (TSX:WEED) (NASDAQ: CGC) is a world-leading
diversified cannabis and cannabinoid-based consumer product
company, driven by a passion to improve lives, end prohibition, and
strengthen communities by unleashing the full potential of
cannabis. Leveraging consumer insights and innovation, we offer
product varieties in high-quality dried flower, oil, softgel
capsule, infused beverage, edible, and topical formats, as well as
vaporizer devices by Canopy Growth and industry-leader Storz &
Bickel. Our global medical brand, Spectrum Therapeutics, sells a
range of full-spectrum products using its colour-coded
classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and
Tokyo Smoke banners, we reach our adult-use consumers and have
built a loyal following by focusing on top quality products and
meaningful customer relationships. Canopy Growth has entered into
the health and wellness consumer space in key markets including
Canada, the United States, and Europe through BioSteel sports nutrition, and
This Works skin and sleep solutions; and has introduced additional
hemp derived CBD products to the United
States through our First & Free and Martha Stewart CBD
brands. Canopy Growth has an established partnership with Fortune
500 alcohol leader Constellation Brands. For more information visit
www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and
"forward-looking information" within the meaning of applicable U.S.
and Canadian securities laws (collectively, "forward-looking
statements"), which involve certain known and unknown risks and
uncertainties. Forward-looking statements predict or describe our
future operations, business plans, business and investment
strategies and the performance of our investments. These
forward-looking statements are generally identified by their
use of such terms and phrases as "intend," "goal," "strategy,"
"estimate," "expect," "project," "projections," "forecasts,"
"plans," "seeks," "anticipates," "potential," "proposed," "will,"
"should," "could," "would," "may," "likely," "designed to,"
"foreseeable future," "believe," "scheduled" and other similar
expressions. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date the
statement was made. Forward‐looking statements are necessarily
based upon a number of estimates and assumptions that, while
considered reasonable by management, are inherently subject to
significant business, economic and competitive risks, financial
results, results, performance or achievements expressed or implied
by those forward‐looking statements and the forward‐looking
statements are not guarantees of future performance. Accordingly,
there are or will be important factors that could cause actual
outcomes or results to differ materially from those indicated in
these statements. A discussion of some of the material factors
applicable to Canopy Growth Corporation ("Canopy") can be found
under the section entitled "Risk Factors" in Canopy's Annual Report
on Form 10-K for the year ended March 31,
2021, filed with the Securities and Exchange Commission and
with applicable Canadian securities regulators, as such factors may
be further updated from time to time in its periodic filings with
the Securities and Exchange Commission and with applicable Canadian
securities regulators, which can be accessed at
www.sec.gov/edgar and www.sedar.com, respectively. These
factors should not be construed as exhaustive and should be read in
conjunction with the other cautionary statements that are included
in this press release and in the filings. Any forward‐looking
statement included in this press release is made as of the date of
this press release and, except as required by law, Canopy disclaims
any obligation to update or revise any forward‐ looking statement.
Readers are cautioned not to put undue reliance on any
forward‐looking statement. Forward-looking statements contained in
this press release are expressly qualified by this cautionary
statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/canopy-growth-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-may-27-2022-301546704.html
SOURCE Canopy Growth Corporation